Skip to main content
FinSpry Logo
FinSpry
MDGL logo
MDGL
(NASDAQ)
Madrigal Pharmaceuticals, Inc.
$543.35-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis

Madrigal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$526.61 - $549.04
52-Week High$615.00
52-Week Low$286.44
Open$537.65
Volume160.51K
Average Volume (3M)382.80K
Market Cap15.77B
Shares Outstanding29.03M
Price to Sales (P/S)13.93
Price to Book (P/B)29.03
EV/EBITDA-53.59
Revenue (TTM)1.13B
Net Income (TTM)-309.44M
Free Cash Flow (TTM)-272.41M
EPS (TTM)$-12.87
Profit Margin-27.32%
Operating Margin-27.68%
Return on Equity (ROE)-56.94%
Debt to Equity0.64
50-Day MA$516.04
200-Day MA$504.54
52-Week Change77.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Madrigal Pharmaceuticals

What is the current stock price for MDGL?

As of the latest trading session, MDGL stock trades at $543.35. The 52-week range is $286.44–$615.00, with a day range of $526.61–$549.04.

What is the P/E ratio for MDGL?

The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.

Does MDGL pay dividends?

Madrigal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDGL?

Based on 10 analysts, the consensus for MDGL is Buy.

What is the market cap of MDGL?

Madrigal Pharmaceuticals's market capitalization is $15.77B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.